FDA's Longtime Approach to New Chemical Entity Designations Now Codified
June 14, 2021
Stacie Ropka, PhD and Ramya Auroprem
Outsourced Pharma and Pharmaceutical Online
Axinn partner Stacie Ropka and associate Ramya Auroprem co-authored the Outsourced Pharma and Pharmaceutical Online article, "FDA's Longtime Approach to New Chemical Entity Designations Now Codified."